Advances in Cardiac Science and Therapeutics
The CorVita Science Foundation hosted its first of many continuing education programs, Advances in Cardiac Science and Therapeutics held on Saturday, October 21, 2017.
Heart and vascular diseases continue to pose significant threats to well-being in our society. The CorVita Science Foundation programs continue to lead care by linking clinical trials and education in treating cardiovascular diseases. Our distinguished members are proud of its roots in education and want to communicate advances in cardiac science and therapeutics to our peers, patients and referring doctors. The Advances in Cardiac Science and Therapeutics Series is designed to present our innovative scientific pursuits as they relate to our clinical expertise.
The goals of this educational program included: updating participants on the latest advances in cardiac science, new therapeutics and evidence-based management, and cutting-edge science and technology in the treatment and management of heart and vascular disease.
Date of Program: Saturday, October 21st, 2017 Registration and Breakfast at 7:30am and ending at 2:00pm
Location: Hilton Garden Inn ~ 18335 LaGrange Road Tinley Park, IL 60487
Target Audience: The intended audience is General Cardiologists, Internists, Hospitalists, Cardiac-Thoracic and Vascular Surgeons, Electrophysiologists and Interventional Cardiologists as well as allied healthcare professionals who treat and manage heart disease.
Educational Grants and Funding: A complete list of commercial support received was provided in the conference materials and can be requested at firstname.lastname@example.org.
The American College of Osteopathic Internists (ACOI) is accredited by the American Osteopathic Association (AOA). ACOI designates this live activity for a maximum of 5.5 AOA Category 1-A Specialty (internal medicine) CME credits to be awarded. Physicians should only claim credit commensurate with the extent of their participation in the educational activity.
8:00 AM Welcome and Introduction to Symposium (Joseph Stella, DO & Martin Burke, DO)
Session I: Advances in Sudden Death Prevention
8:05 AM The Rationale Behind the CV Risk Score: Are lipid levels really needed? (John Panozzo, MD)
8:30 AM Selecting the Best ICD: What, Who, When (Martin Burke, DO)
Session II: Minimally Invasive Treatment Paradigms in Structural Heart & Vascular Disease
9:00 AM TAVR 2017: Transcatheter Aortic Valve Replacement (Ravi Ramana, DO)
9:25 AM The next valve: Percutaneous Mitral Valve Repair and Replacement (James Flaherty, MD)
9:50 AM Peripheral Vascular Disease Who to Screen; Best Fix (James Sur, MD)
10:15 AM Panel Discussion
10:30 AM Refreshment Break and Exhibits
Session III: Late Breaking Clinical Trials
10:45 AM Value of Clinical Research Enrollment in Clinical Practice (Martin Burke, DO)
Session IV: Cardiac Pump Failure
11:05 AM Pulmonary Hypertension: Lest We Forget the Right Heart (James Sur, MD)
11:30 AM New Monitoring Options to Prevent Readmission (Gregory Macaluso, MD)
11:55 AM Advanced Heart Failure: When to Refer for Pharma Failure (Gregory Macaluso, MD)
12:10 PM Panel Discussion & Lunch
Session V: Atrial Fibrillation: The New Epidemic
1:00 PM Stroke Prevention: Aspirin, Anticoagulants, Appendage Occlusion (Martin Burke, DO)
1:30 PM Atrial Fibrillation Ablation Outcomes 2017: Best Responders (Wassim Ballany, MD)
2:00 PM Adjourn
For questions about the event please email email@example.com